ANNOUNCEMENT: Divestment of portfolio to Strides

As of 1 September 2015 Aspen has divested to Strides (Australia) Pharma Pty Ltd a portfolio of its products commercialised in Australia and New Zealand. The range primarily includes the Aspen Generics Product Portfolio and business, including the Chemists’ Own range. Strides, to be called Arrow Pharmaceuticals in Australia, has a core focus on generic product development, and with its strong manufacturing and procurement capabilities has better opportunities to promote and grow this portfolio.

The Aspen generics sales team have transitioned to Arrow Pharmaceuticals and are responsible for the ongoing promotion of the Generics Product Portfolio, including the Chemists’ Own range.

For all sales and marketing questions you have in relation to the Generics or Chemists’ Own portfolio of products- such as pricing – please contact Arrow on 1300 9 27769 or visit Arrow Pharma Pty Ltd.

Aspen will distribute the generics portfolio for Arrow Pharmaceuticals for a transitional period to provide a seamless transition for our customers.

Post the generics divestment, the Aspen Australia business will continue with our large portfolio of prescription, OTC, and infant nutritional brands. If you have any questions please do not hesitate to contact your local Aspen representative for clarification, or call Aspen Customer Service on 1300 659 646.